Royer B, Brière J
Service d'Anatomie-Pathologie, Hôpital Laënnec, Paris.
Arch Anat Cytol Pathol. 1995;43(1-2):77-81.
Although very rare (0.12 to 1.1% of all breast tumours), primary non-Hodgkin's lymphomas of the breast need to be distinguished from the group of malignant epithelial tumours, as the staging and therapeutic modalities are different, corresponding to those applied to lymphomas in general. In the majority of cases, the current techniques of aspiration cytology, needle or surgical biopsy, immunohistochemistry allow the diagnosis and typing according to the usual histological classifications.
尽管乳腺原发性非霍奇金淋巴瘤非常罕见（占所有乳腺肿瘤的0.12%至1.1%），但由于其分期和治疗方式与一般淋巴瘤相同，与恶性上皮性肿瘤不同，因此需要加以区分。在大多数情况下，目前的细针穿刺细胞学、针吸活检或手术活检、免疫组织化学技术能够根据常见的组织学分类进行诊断和分型。
